Abstract
The need for blood transfusion is one the rise because of rapid population growth, development of new infections, accidents and natural disasters. One of the future evolutionary innovations could be artificial blood substitutes which is the most important need in transfusion medicine. Encapsulation of hemoglobin within a liposome is one of the recent strategies in the production of artificial oxygen carriers. In this review we summarize the role of liposome encapsulated haemoglobin (LEH) as artificial oxygen carrier. In addition, the steps taken toward the development of LEH as artificial blood technology and some of their applications and limitations were highlighted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Biochemistry & Physiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
